Clinical Trial Update: Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

Phase 4 trial comparing optimized bismuth quadruple therapy versus triple standard therapy for Helicobacter pylori eradication has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Optimized Bismuth Quadruple Therapy
• Triple Standard Therapy

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED